三维全肝MRI动态增强扫描定量分析在肝脏肿瘤诊断中的应用
The application of the quantitative analysis of three-dimensional whole-liver DCE-MRI in the diagnosis of hepatic tumors
-
摘要: 目的:研究肝细胞肝癌(HCC)、肝转移瘤(HM)和肝血管瘤(HH)患者的肝动脉灌注指数(HPI)以及血管渗透性参数,探讨三维全肝MRI动态增强扫描定量分析在鉴别诊断肝脏肿瘤中的价值。方法:选取58例受检者(HCC组30例,HM组16例,HH组12例),采用三维容积内插体部检查(VIBE)序列进行全肝磁共振动态增强扫描(DCE-MRI),并用Omni-Kinetics软件分析图像,结合肝脏双输入血流动力学模型获得肝脏灌注和血管渗透性参数HPI、容积转运常数(Ktrans)、回流速率常数(kep)、血管外细胞外间隙体积比(ve)值和血浆空间容积率(vp)。结果:3组HPI值、Ktrans和kep值差异均有统计学意义(P < 0.05~P < 0.01);HPI值HCC组 > HH组 > HM组(P<0.05);Ktrans值HCC组 > HH组 > HM组(P < 0.05~P < 0.01);kep值HCC组>HH组和HM组(P<0.01),但HH组和HM组的kep值差异无统计学意义(P>0.05);3组ve和vp值差异均无统计学意义(P>0.05)。结论:三维全肝DCE-MRI扫描可获得定量血流灌注及血管渗透性参数,有助于肝脏肿瘤的鉴别诊断。Abstract: Objective: To investigate the hepatic perfusion index(HPI) and vascular permeability parameters in patients with different hepatic tumors,which included hepatocellular carcinoma(HCC),hepatic metastasis(HM) and hepatic haemangiomas(HH),and discuss the clinical diagnosis value of DCE-MRI.Methods: Fifty-eight patients with hepatic tumors(30 cases of HCC,16 cases of HM and 12 cases HH) were detected by the 3D whole-liver dynamic contrast enhance MRI(DCE-MRI) using volumetric interpolated body examination(VIBE) sequence.The perfusion and vascular permeability parameters(including HPI,Ktrans,kep,ve and vp) were measured by the Omni-Kinetics software combined with liver model of dual input hemodynamics.Results: There was statistical difference in the values of HPI,Ktrans and kep between three groups(P<0.05 to P<0.01).The HPI value in HCC group was significantly higher than that in HH group,and the HPI value was the lowest in HM group(P<0.05).The Ktrans value in HH group was significantly lower than that in HCC group,and the value was the lowest in HM group(P<0.05 to P<0.01).The kep value in HCC group was higher than that in HH and HM groups(P<0.01),but there was no statistical difference between HH and HM groups(P>0.05).The differences of the vp and ve values between three groups were not statistically significant(P>0.05).Conclusions: Three-dimensional whole-liver DCE-MRI with the bolus injection of gadodiamide can be used to quantify the perfusion and permeability parameters of hepatic tumors,which is benefit to the differentiation diagnosis of hepatic tumors.
-
Key words:
- hepatic tumor /
- magnetic resonance imaging /
- liver /
- dynamic contrast enhancement
-
[1] KOH DM,SCURR E,COLLINS DJ,et al.Colorectal hepatic metastases:quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging[J].Eur Rad,2006,16(9):1898. [2] SOURBRON SP,BUCKLEY DL.On the Scope and Interpretation of the Tofts Models for DCE-MRI[J].Magn Reson Med,2011,66(3):735. [3] MIYAZAKI K,COLLINS DJ,WALKER-SAMUEL S,et al.Quantitative mapping of hepatic perfusion index using MR imaging:a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120,a potent triple angiokinase inhibitor[J].Eur Rad,2008,18(7):1414. [4] 李静.血管内皮生长因子与血液肿瘤的相关性研究[J].蚌埠医学院学报,2012,37(3):364. [5] 仵志远,姜德清,郝占伟.CD147和基质金属蛋白酶-9在肝细胞肝癌中的表达与微血管生成的相关性[J].蚌埠医学院学报,2015,40(4):450. [6] 王化,王伟,唐光健.肝细胞癌影像学诊断的现状与进展[J].中华放射学杂志,2006,40(3):315. [7] 李智岗,黄景香,李顺宗,等.肝转移瘤的血供[J].北京大学学报(医学版),2008,40(2):146. [8] JIANG H,LU H,ZHANG Z,et al.Experimental study on angiogenesis in a rabbit VX2 early liver tumour by perfusion computed tomography[J].J Intern Med Res,2010,38(3):929. [9] YUN TJ,PARK CK,KIM TM,et al.Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy:differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging[J].Radiology,2015,274(3):830. [10] 李金平,姜慧杰.多层螺旋CT灌注参数对肝癌血流变化的诊断价值[J].中国医学计算机成像杂志,2011,17(4):377. [11] CHIKUI T,KITAMOTO E,KAWANO S,et al.Pharmacokinetic analysis based on dynamic contrast-enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer[J].J Magn Reson Imaging,2012,36(3):589. [12] KIM JH,KIM CK,PARK BK,et al.Dynamic contrast-enhanced 3-T MR imaging in cervical cancer before and after concurrent chemoradiotherapy[J].Eur Rad,2012,22(11):2533. [13] SAHANI DV,JIANG T,HAYANO K,et al.Magnetic resonance imaging biomarkers in hepatocellular carcinoma:association with response and circulating biomarkers after sunitinib therapy[J].J Hematol Oncol,2013,6:51.
计量
- 文章访问数: 4237
- HTML全文浏览量: 688
- PDF下载量: 97
- 被引次数: 0